CME
Immune-Based Advances in Gastric, Esophageal, and Gastroesophageal Junction Cancers
November 15, 2022
Host: Eric Van Cutsem, MD, PhD Guest: Elizabeth Smyth, MD Guest: Sunnie Kim, MD Recent immunotherapy approvals for gastric, esophageal, and gastroesophageal junction cancers have transformed the treatment landscape. Listen in as Drs. Eric Van Cut
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!